Gyrodyne, LLC (NASDAQ:GYRO – Get Rating)'s stock price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $8.84 and traded as low as $8.83. Gyrodyne shares last traded at $8.83, with a volume of 110 shares changing hands.
Gyrodyne Stock Performance
The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.32. The company's 50 day moving average price is $8.58 and its 200-day moving average price is $8.84.
Get Gyrodyne alerts:Institutional Inflows and Outflows
A hedge fund recently raised its stake in Gyrodyne stock. Gabelli Funds LLC lifted its stake in shares of Gyrodyne, LLC (NASDAQ:GYRO – Get Rating) by 0.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 145,437 shares of the real estate investment trust's stock after acquiring an additional 1,333 shares during the quarter. Gabelli Funds LLC owned 9.83% of Gyrodyne worth $1,178,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 41.39% of the company's stock.
Gyrodyne Company Profile
(Get Rating)
Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.
Further Reading
- Get a free copy of the StockNews.com research report on Gyrodyne (GYRO)
- Medtronic: Reversal In-Play For This High-Yield Stock
- Is it 'Game Over' for Roblox After Reporting March Metrics Miss?
- Is it Time to Take Profits in Chip Stocks?
- Will Stratasys Continue to be a Runaway Bride?
- Garrett Motion Inc. Skids on Results: Is it Time to Buy the Dip?
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.